Skip to main content
. Author manuscript; available in PMC: 2021 Mar 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2020 Oct 23;86(6):815–827. doi: 10.1007/s00280-020-04176-z

Fig. 3.

Fig. 3

Clinical response a patient with adenocarcinoma of the palate with corresponding HSP70 measurements in plasma and PBMC. a Computed tomography scan demonstrating partial response of thoracic metastases (arrow) at baseline (Top) and at 13 cycles (Bottom). Right-sided panels show corresponding: b changes in soluble HSP70 protein expression in plasma as measured by ELISA at C0D1, C0D4 and C1D11; and c ImageQuant quantitated changes in HSP70 protein expression as measured by western blot in PBMCs at C0D1, C0D4 and C1D11